IN THIS ARTICLE

Citations

1. Petri MA, et al. (2005). Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine, 353(24): 2550–2558.

2. Wofsy D (2005). Therapy of systemic lupus erythematosus. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 1561–1574. Philadelphia: Lippincott Williams and Wilkins.

3. Ghaussy NO, et al. (2003). Cigarette smoking and disease activity in systemic lupus erythematosus. Journal of Rheumatology, 30(6): 1215–1221.

4. Crosbie D, et al. (2009). Dehydroepiandrosterone for systemic lupus erythematosus (review). Cochrane Database of Systematic Reviews (4).

5. Crow MK (2008). Systemic lupus erythematosus. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 23rd ed., pp. 2022–2032. Philadelphia: Saunders Elsevier.

Other Works Consulted

• Bernier MO, et al. (2009). Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis and Rheumatism (Arthritis Care and Research), 61(4): 476–481.

• Bertsias GK, et al. (2007). EULAR recommendations for the management of systemic lupus erythematosus (SLE) report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases, 67(2): 195–205.

• Madhok R, Wu O (2006). Systemic lupus erythematosus, search date April 2006. Online version of Clinical Evidence (15): 1–12.

• McMurray RW, May W (2003). Sex hormones and systemic lupus erythematosus: Review and meta-analysis. Arthritis and Rheumatism, 48(8): 2100–2110.